Treatment of advanced soft tissue sarcomas with ifosfamide (IFF) and adriamycin (ADM)
نویسندگان
چکیده
منابع مشابه
neoadjuvant chemotherapy with ifosfamide, cisplatin, adriamycin and mitomycin (imap) for high risk adult soft tissue sarcomas
to define efficacy of pre-operative chemotherapy in down staging of advanced non-round cell soft tissue sarcomas. from sep 2002 to dec 2005, 70 patients were treated by ifosfamid, mesna, cisplatin, adriamycin, mitomycin and subsequent surgery. postoperatively, patients received radiotherapy in cases of microscopically incomplete resection or local recurrence. the median age of the patients was ...
متن کاملIfosfamide with regional hyperthermia in soft-tissue sarcomas.
For high-risk soft tissue sarcomas (HR-STS) of adults, new treatment strategies are needed to improve outcome with regard to local control and overall survival. Therefore, systemic chemotherapy has been integrated either after (adjuvant) or before (neoadjuvant) optimal local treatment by surgery and radiotherapy in HR-STS. The combination with regional hyperthermia as a new treatment strategy s...
متن کاملProgress in the Systemic Treatment of Advanced Soft-Tissue Sarcomas.
BACKGROUND: Despite the plethora of chemotherapeutic remedies for advanced soft-tissue sarcomas, little evidence has developed to indicate that these efforts have been curative. No controlled comparison has yet proven that patients receiving multidrug regimens survive longer than those receiving doxorubicin alone. METHODS: The authors review current systemic treatments and then discuss some inv...
متن کامل[Treatment of bone and soft tissue sarcomas].
Why should wait for some days to get or receive the treatment of bone and soft tissue sarcomas book that you order? Why should you take it if you can get the faster one? You can find the same book that you order right here. This is it the book that you can receive directly after purchasing. This treatment of bone and soft tissue sarcomas is well known book in the world, of course many people wi...
متن کاملSystemic Therapy for Advanced Soft Tissue Sarcomas
Soft tissue sarcomas (STS) are a rare, heterogeneous group of solid tumors in need of improved therapeutic options. First-line chemotherapy is considered the current standard of care for patients with advanced, symptomatic STS, but the median survival is only 8 to 12 months. Efforts to increase response rates by using combination or dose-dense regimens have largely failed to improve patient out...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cancer Research and Clinical Oncology
سال: 1986
ISSN: 0171-5216,1432-1335
DOI: 10.1007/bf02579890